Identification and Characterization of Drug Targets in ATCC 700669 (Serotype 23F) by Subtractive Genomics.

is an important pathogen worldwide that causes pneumococcal infections which are related to high rates of morbidity and mortality especially in young children, older adults, and immune-compromised persons. Antibiotic resistance in is a serious problem across the world from time to time, resulting in treatment failure and diminished value of older medicines. Therefore, the objective of this study was to identify new putative drug targets against serotype 23F by using subtractive genomics.